George Badescu

Company: Heidelberg Pharma

Job title: Chief Business Officer

Seminars:

12:00pm Overcoming Tumor Resistance With Amanitin-Based ADCs – Insights From the Clinic 12:00 pm

Discussing the trends and advantages of dual-payload ADCs to combat resistance Overviewing dual-payload ADCs generated from the co-Nectar platform Sharing HoneyBear Biosciences portfolio of dual-payload ADCs, and future plansRead more

day: Day One Preclinical & Clinical Development Track